Allergic disorders | Asthma, allergic rhinitis, atopic dermatitis | Drug hypersensitivity (eg, drug reaction with eosinophilia and systemic symptoms [DRESS], eosinophilia-myalgia syndrome, interstitial nephritis, eosinophilic hepatitis) | Infectious diseases | Helminths (eg, strongyloidiasis, trichinellosis, filariasis, toxocariasis, schistosomiasis, hookworm) | Ectoparasites (eg, scabies, myiasis) | Protozoans (eg, isosporiasis, sarcocystis myositis) | Fungi (eg, coccidiomycosis, allergic bronchopulmonary aspergillosis, histoplasmosis) | Viral (eg, HIV) | Neoplastic disorders | Primary hypereosinophilic syndromes (eg, FIP1L1-PDGFRA, -PDGFRB, -FGFR1 rearrangement) | Acute or chronic eosinophilic leukemia | Other myeloid neoplasms (eg, chronic myeloid leukemia, systemic mastocytosis) | Lymphoid malignancies (eg, B cell lymphoma, B or T lymphoblastic leukemia/lymphoma, adult T cell leukemia/lymphoma, cutaneous T cell lymphoma/Sézary syndrome) | Solid tumors (eg, adenocarcinoma, squamous carcinoma) | | Immunologic disorders | Immunodeficiencies (eg, DOCK8 deficiency, hyper-IgE syndrome, Omenn syndrome) | Autoimmune and idiopathic disorders (eg, sarcoidosis, inflammatory bowel disease, IgG4 disease, other connective tissue disorders) | Eosinophilic disorders | Idiopathic hypereosinophilic syndrome | Eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome) | Eosinophilic gastrointestinal disorders | Miscellaneous | Radiation exposure | Cholesterol emboli | Hypoadrenalism | IL-2 therapy | |